View Item 

Show simple item record

Completion lymphadenectomy for sentinel node positive cutaneous head & neck melanoma
dc.contributor.authorSchmalbach, Cecelia E.
dc.contributor.authorBradford, Carol R.
dc.date.accessioned2018-03-07T18:26:18Z
dc.date.available2019-04-01T15:01:10Zen
dc.date.issued2018-02
dc.identifier.citationSchmalbach, Cecelia E.; Bradford, Carol R. (2018). "Completion lymphadenectomy for sentinel node positive cutaneous head & neck melanoma." Laryngoscope Investigative Otolaryngology 3(1): 43-48.
dc.identifier.issn2378-8038
dc.identifier.issn2378-8038
dc.identifier.urihttps://hdl.handle.net/2027.42/142560
dc.description.abstractThe application and utility of melanoma sentinel lymph node biopsy (SLNB) has evolved significantly since its inception over two decades ago. The current focus has shifted from a staging modality to potentially a therapeutic intervention. Recent research to include large multi‐institutional randomized trials have attempted to answer the question: is a completion lymph node dissection (CLND) required following a positive SLNB? This review provides an evidence‐based, contemporary review of the utility of CLND for SLNB positive head and neck cutaneous melanoma patients.Level of EvidenceNA
dc.publisherWiley Periodicals, Inc.
dc.subject.othercompletion lymphadenectomy
dc.subject.othersentinel node biopsy
dc.subject.otherMelanoma
dc.titleCompletion lymphadenectomy for sentinel node positive cutaneous head & neck melanoma
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOtolaryngology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/142560/1/lio2136.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/142560/2/lio2136_am.pdf
dc.identifier.doi10.1002/lio2.136
dc.identifier.sourceLaryngoscope Investigative Otolaryngology
dc.identifier.citedreferenceLeiter U, Stadler R, Mauch C, et al. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG‐SLT): a multicenter, randomized, phase 3 trial. Lancet Oncol 2016; 17: 757 – 767.
dc.identifier.citedreferenceVan Akkooi AC, de Wilt JH, Verhoef C, et al. Clinical relevance of melanoma micrometastasis (<0.1mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol 2006; 17: 1578 – 1585.
dc.identifier.citedreferenceBamboat ZM, Konstantinidis IT, Kuk D, et al. Observation after a positive sentinel lymph node biopsy in patient with melanoma. Ann Surg Oncol 2014; 21: 3117 – 3123.
dc.identifier.citedreferenceWong SL, Morton DL, Thompson JF, et al. Melanoma patients with positive sentinel lymph nodes who did not undergo completion lymphadenectomy: a multi‐insitutional study. Ann Surg Oncol 2006; 13: 809 – 816.
dc.identifier.citedreferenceKingham TP, Panageas KS, Ariyan CE, Busam KJ, Brady MS, Coit DG. Outcome of patients with a positive sentinel lymph node who do not undergo completion lymphadenectomy. Ann Surg Oncol 2010; 17: 514 – 520.
dc.identifier.citedreferencevan der Ploeg AP, van Akkooi aC, Rutkowski P, et al. Prognosis in patients with sentinel node‐positive melanoma without immediate completion lymph node dissection. Br J Surg 2012; 99: 1396 – 1405.
dc.identifier.citedreferenceLeong SP. Role of selective sentinel lymph node dissection in head and neck melanoma. J Surg Oncol 2011; 104: 361 – 368.
dc.identifier.citedreferenceFaris MB, Thomspon JF, Cochran AJ, et al. Completion dissection or observation for sentinel‐node metastasis in melanoma. N Engl J Med 2017; 376: 2211 – 2222.
dc.identifier.citedreferenceMinimal SN Tumor Burden (Minitub). European Organisation for treatment and research in cancer: NCT01942603. https://clinicaltrials.gov/ct2/show/NCT01942603. Accessed September 9, 2017.
dc.identifier.citedreferenceSmith VA, Cunningham JE, Lentsch EJ. Completion node dissection in patients with sentinel node‐positive melanoma of the head and neck. Otolaryngol Head Neck Surg 2011; 146: 591 – 599.
dc.identifier.citedreferenceBalch CM, Soong S, Ross MI, et al. Long‐term results of a multi‐institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 2000; 7: 87 – 97.
dc.identifier.citedreferenceAriyan C, Brady MS, Gonen M, Busam K, Coit D. Positive nonsentinel node status predicts morality in patients with cutaneous melanoma. Ann Surg Oncol 2009; 16: 186 – 190.
dc.identifier.citedreferenceGershenwald JE, Andtbacka RH, Prieto VG, et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol 2008; 26: 4296 – 4303.
dc.identifier.citedreferenceQuaglino P, Ribero S, Osella‐Abate S, et al. Clinico‐pathologic features of primary melanoma and sentinel lymph node predictive for non‐sentinel lymph node involvement and overall survival in melanoma patients: a single centre observation cohort study. Surg Oncol 2011; 20: 259 – 264.
dc.identifier.citedreferenceSabe MS, Griffith K, Sondak VK, et al. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. J Am Coll Surg 1992; 127: 392 – 399.
dc.identifier.citedreferenceFristsch VA, Cunningham JE, Lentsch EJ. Completion lymph node dissection based on risk of nonsentinel metastasis in cutaneous melanoma of the head and neck. Otolaryngol Head Neck Surg 2016; 154: 94 – 103.
dc.identifier.citedreferenceWrightson WR, Wong SL, Edwards MJ, et al. Reverse transcriptase‐polymerase chain reaction (RT‐PCR) analysis of nonsentinel nodes following completion lymphadenectomy for melanoma. J Surg Res 2001; 98: 47 – 51.
dc.identifier.citedreferenceMoody JA, Botham SJ, Dahill KE, Wallace DL, Hardwickle JT. Complications following completion lymphadenectomy versus therapeutic lymphadenectomy for melanoma—A systematic review of the literature. Eur J Surg Oncol 2017; 43: 1760 – 1767.
dc.identifier.citedreferenceOlilia DW, Ashburn JH, Amos KD, et al. Metastatic melanoma cells in the sentinel node cannot be ignored. J Am Coll Surg 2009; 108: 924 – 930.
dc.identifier.citedreferenceSiegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017; 67: 7 – 30.
dc.identifier.citedreferenceBalch CM, Gershenwald JE, Soong SJ, et al. Final version of the 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199 – 6206.
dc.identifier.citedreferenceMorton DL, Wen DR, Won JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392 – 399.
dc.identifier.citedreferenceSim FH, Taylor WF, Ivins JC, Pritchard DJ, Soule EH. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Cancer 1978; 41: 948 – 956.
dc.identifier.citedreferenceCascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomized trial. WHO Melanoma Programme. Lancet 1998; 351: 793 – 796.
dc.identifier.citedreferenceVeronesi U, Adamus J, Bandiera DC, et al. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med 1977; 297: 627 – 630.
dc.identifier.citedreferenceBach CM, Soong BJ, Barolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996; 224: 255 – 263.
dc.identifier.citedreferenceNational Comprehensive Cancer Network. Melanoma. V.1.2017. https://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed September 8, 2017.
dc.identifier.citedreferenceWong SL, Balch CM, Hurley P, et al. Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guidelines. Ann Surg Oncol 2012; 19: 3313 – 3324.
dc.identifier.citedreferenceBichakjian CK, Halpern AC, Johnson TM, et al. Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology. J Am Acad Dermatol 2011; 65: 1032 – 1047.
dc.identifier.citedreferenceCascinelli N. WHO declares lymphatic mapping to be standard of care for melanoma. Available at: http://www.cancernetwork.com/articles/who-delcares-lymphatic-mapping-be-standard-care-melanoam. Accessed August 22, 2017.
dc.identifier.citedreferenceSchmalbach CE, Bradford CR. Is sentinel lymph node biopsy the standard of care for cutaneous head and neck melanoma. Laryngoscope 2015; 125: 153 – 160.
dc.identifier.citedreferenceSchmalbach CE, Nussenbaum B, Rees RS, Schwartz J, Johnson TM, Bradford CR. Reliability of sentinel lymph node mapping with biopsy for head and neck cutaneous melanoma. Arch Otolaryngol Head Neck Surg 2003; 129: 61 – 65.
dc.identifier.citedreferencede Rosa N, Lyman GH, Silbermins D, et al. Sentine node biopsy for head and neck melanoma: a systematic review. Arch Otolaryngol Head Neck Surg 2011; 145: 375 – 382.
dc.identifier.citedreferenceAlex JC, Krag DN, Harlow SP, et al. Localization of regional lymph nodes in melanomas of the head and neck. Arch Otolaryngol Head Neck Surg 1998; 124: 1350140.
dc.identifier.citedreferenceErman AB, Collar RM, Griffith KA, et al. Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma. Cancer 2012; 118: 1040 – 1047.
dc.identifier.citedreferenceComez‐Rivera F, Santillan A, McMurphy AB, et al. Sentinel node biopsy in patients with cutaneous melanoma of the head and neck: recurrence and survival study. Head Neck 2008; 30: 1284 – 1294.
dc.identifier.citedreferenceFincher TR, McCarty TM, Fisher TL, et al. Patterns of recurrence after sentinel lymph node biopsy for cutaneous melanoma. Am J Surg 2003; 186: 675 – 681.
dc.identifier.citedreferenceChao C, Wong SL, Ross MI, et al. Patterns of early recurrence after sentinel lymph node biopsy for melanoma. Am J Surg 2002; 184: 520 – 524.
dc.identifier.citedreferenceBilimoria KY, Balch CM, Bentrem DJ, et al. Complete lymph node dissection for sentinel node‐positive melanoma: assessment of practice patterns in the United States. Ann Surg Oncol 2008; 15: 1566 – 1576.
dc.identifier.citedreferenceMosquera C, Vora HS, Vohra N, Fitzgeral TL. Population–based analysis of completion lymphadenectomy in intermediate‐thickness melanoma. Ann Surg Oncol 2017; 24: 127 – 134.
dc.identifier.citedreferenceBalch CM, Gershenwald JE, Soong SJ, et al. Multivariate analysis of prognostic factors among 2,313 patient with stage III melanoma: comparison of nodal micrometastases versus macrometastasis. J Clin Oncol 2010; 28: 2452 – 2459.
dc.identifier.citedreferenceVan Akkooi ACJ, Nowecki Z, Voit C, et al. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients. A multicenter study in 388 patients with positive sentinel nodes. Ann Surg 2008; 248: 949 – 955.
dc.identifier.citedreferenceStarz H, Siedlecki K, Balda BR. Sentinel lymphonodectomy and s‐classification: a successful strategy for better prediction and improvement of outcome of melanoma. Ann Surg Oncol 2004; 11 ( 3 Suppl ): 162S – 168S.
dc.identifier.citedreferenceVan der Ploeg AP, van Akkooi AC, Schmitz Pl, et al. EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria. Eur J Cancer 2010; 46: 2414 – 2421.
dc.identifier.citedreferenceMeier A, Satzger I, Volker B, et al. Comparison of classification systems in melanoma sentinel lymph nodes‐ an analysis of 697 patients from a single center. Cancer 2010; 116: 3178 – 3188.
dc.identifier.citedreferenceVan Der Ploeg AP, van Akkoi AC, Rutkowski P, et al. Prognosis in patients with sentinel node‐positive melanoma is accurately defined by the combined Rotterdam tumor load and dewar topography criteria. J Clin Oncol 2011; 29: 2206 – 2214.
dc.identifier.citedreferenceMurali R, DeSilva C, McCarthy SW, et al. Sentinel lymph nodes containing very small (<0.1mm) deposits of metastatic melanoma cannot be safely regarded as tumor‐negative. Ann Surg Oncol 2012; 19: 1089 – 1099.
dc.identifier.citedreferenceVan Der Ploeg AP, van Akkoi AC, Verhoef C, Eggermon AM. Completion lymph node dissection after a positive sentinel node: no longer a must? Curr Opin Oncol 2013; 25: 152 – 159.
dc.identifier.citedreferenceDewar DJ, Newell B, Green MA, et al. The microanatomic location of the metastatic melanoma in sentine lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 2004; 22: 3345 – 3349.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
lio2136.pdf
Size:
147.6KB
Format:
PDF
View/Open
Name:
lio2136_am.pdf
Size:
247.4KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.